[Federal Register Volume 68, Number 130 (Tuesday, July 8, 2003)]
[Notices]
[Page 40686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-17125]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 21, 2003, Lilly Del 
Caribe, Inc., Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, 
Puerto Rico 00680, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
Dextropropoxyphene (9273), a basic class of controlled substance listed 
in Schedule II.
    The firm plans to bulk manufacture product for distribution to its 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than September 
8, 2003.

    Dated: June 20, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-17125 Filed 7-7-03; 8:45 am]
BILLING CODE 4410-09-M